These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37479967)

  • 21. Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction.
    Chen K; Li Y; Wang B; Yan X; Tao Y; Song W; Xi Z; He K; Xia Q
    Front Immunol; 2023; 14():1101324. PubMed ID: 37215109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in patient-derived tumor organoids for reconstructing TME of head and neck cancer.
    Chen L; Chen Y; Ge L; Zhang Q; Meng J
    J Oral Pathol Med; 2024 Apr; 53(4):238-245. PubMed ID: 38561906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
    Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
    J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.
    Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S
    Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing.
    Fashemi BE; van Biljon L; Rodriguez J; Graham O; Mullen M; Khabele D
    J Vis Exp; 2023 Sep; (199):. PubMed ID: 37782106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
    Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastric cancer patient-derived organoids model for the therapeutic drug screening.
    Xu J; Gong J; Li M; Kang Y; Ma J; Wang X; Liang X; Qi X; Yu B; Yang J
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130566. PubMed ID: 38244703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor Organoids: The Era of Personalized Medicine.
    Rassomakhina NV; Ryazanova AY; Likhov AR; Bruskin SA; Maloshenok LG; Zherdeva VV
    Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S127-S147. PubMed ID: 38621748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms.
    Hogstrom JM; Cruz KA; Selfors LM; Ward MN; Mehta TS; Kanarek N; Philips J; Dialani V; Wulf G; Collins LC; Patel JM; Muranen T
    J Biol Chem; 2023 Aug; 299(8):105021. PubMed ID: 37423299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-Derived Cancer Organoids for Precision Oncology Treatment.
    Pernik MN; Bird CE; Traylor JI; Shi DD; Richardson TE; McBrayer SK; Abdullah KG
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34067714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
    Guillen KP; Fujita M; Butterfield AJ; Scherer SD; Bailey MH; Chu Z; DeRose YS; Zhao L; Cortes-Sanchez E; Yang CH; Toner J; Wang G; Qiao Y; Huang X; Greenland JA; Vahrenkamp JM; Lum DH; Factor RE; Nelson EW; Matsen CB; Poretta JM; Rosenthal R; Beck AC; Buys SS; Vaklavas C; Ward JH; Jensen RL; Jones KB; Li Z; Oesterreich S; Dobrolecki LE; Pathi SS; Woo XY; Berrett KC; Wadsworth ME; Chuang JH; Lewis MT; Marth GT; Gertz J; Varley KE; Welm BE; Welm AL
    Nat Cancer; 2022 Feb; 3(2):232-250. PubMed ID: 35221336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient- and xenograft-derived organoids recapitulate pediatric brain tumor features and patient treatments.
    Lago C; Federico A; Leva G; Mack NL; Schwalm B; Ballabio C; Gianesello M; Abballe L; Giovannoni I; Reddel S; Rossi S; Leone N; Carai A; Mastronuzzi A; Bisio A; Soldano A; Quintarelli C; Locatelli F; Kool M; Miele E; Tiberi L
    EMBO Mol Med; 2023 Dec; 15(12):e18199. PubMed ID: 38037472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC-Derived Organoids.
    Huang L; Xu Y; Wang N; Yi K; Xi X; Si H; Zhang Q; Xiang M; Rong Y; Yuan Y; Wang F
    Small Methods; 2024 Jan; 8(1):e2301009. PubMed ID: 37882328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends.
    Song SL; Li B; Carvalho MR; Wang HJ; Mao DL; Wei JT; Chen W; Weng ZH; Chen YC; Deng CX; Reis RL; Oliveira JM; He YL; Yan LP; Zhang CH
    Pharmacol Ther; 2022 Nov; 239():108276. PubMed ID: 36055421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
    Yoon H; Lee S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].
    Pauli C; Moch H; Rubin MA
    Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.